PATENT CLAIM ANALYSIS

Application Number: 16207515
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "401000"]

Abstract:
A microcapsule composition comprising at least one polymer substantially disposed as a semi-permeable shell around a buffered solution and at least one therapeutic agent, wherein the therapeutic agent permeates the shell, and wherein the composition is suitable for topical epithelial cells of mammal.

Claim (Index 13):
The microcapsule composition of  claim 1 , wherein the therapeutic agent is a natural antimicrobial agent selected from the group consisting of: beta lactam antiobiotics such as penicillins or cephalosporins, protein synthesis inhibitors such as aminoglycosides, macrolides, ketolides, tetracyclines, chloramphenicol, and polypeptides; penicillins including: penicillin G, procaine penicillin, benzathine penicillin, and penicillin V; cephalosporins including: cefacetrile, cefadroxil, cephalexin, cefaloglycin, cefalonium, cefaloridine, cefalotin, cefapirin, cefatrizine, cefazaflur, cefazedone, cefazolin, cefradine, cefroxadine, ceftezole, cefaclor, cefonicid, cefprozil, cefuroxime, cefuzonam, cefmetazole, cefotetan and cefoxitin; aminoglycosides including: amikacin, arbekacin, gentamicin, kanamycin, neomycin, netilmicin, paromomycin, rhodostreptomycin, streptomycin, tobramycin, and apramycin; Macrolides including: azithromycin, clarithromycin, dirithromycin, erythromycin, roxithromycin, and telithromycin; Ketolides including: telithromycin, cethromycin, solithromycin, spiramycin, ansamycin, oleandomycin, carbomycin and tylosin; naturally occurring tetracyclines including: tetracycline, chlortetracycline, oxytetracycline, and demeclocycline; semi-synthetic tetracyclines including: doxycycline, lymecycline, meclocycline, methacycline, minocycline and rolitetracycline; polypeptides including: actinomycin, bacitracin, colistin, and polymyxin B; synthetic antimicrobial agents including: sulphonamides, cotrimoxazole, quinolones, antivirals, antifungals, anticancer drugs, antimalarials, antituberculosis drugs, antileprotics and antiprotozoals; sulphonamide antibacterials including: sulfamethoxazole, sulfisomidine, sulfacetamide, sulfadoxine, dichlorphenamide, and dorzolamide; Sulphonamide diuretics including: acetazolamide, bumetanide, chlorthalidone, clopamide, furosemide, hydrochlorothiazide, indapamide, mefruside, metolazone, and xipamide; sulphonamide anticonvulsants including: acetazolamide, ethoxzolamide, sultiame and zonisamide; and other sulfonamide therapeutic agents including: celecoxib, darunavir, probenecid, sulfasalazine, and sumatriptan.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 98.0
- Lexical Diversity: 1.39394
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15921269', '13619128', '15921350', '15791554', '16207545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.817486232097882
- 35 USC 102 Novelty (BERT): 0.5609213768717527
- Combined Prediction Score: 0.7918297465752691
- Mean Citation Score: 407.626938
- Max Citation Score: 425.89395
- Similarity Product: 410.32969008870725

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test